While most MS genetics studies in North European, Caucasian populations suggest the HLA-DRB1*15:01 as the genetic risk factor in MS (5), Spurkland, Thorsby, and Vartdal studied the specific HLA-DR and DQ alleles of 181 Norwegian MS patients. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.